Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition

High-quality epidemiologic data worldwide are needed to improve our understanding of disease risk, support health policy to meet the diverse needs of people with multiple sclerosis (MS) and support advocacy efforts. The Atlas of MS is an open-source global compendium of data regarding the epidemiolo...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Multiple sclerosis Ročník 26; číslo 14; s. 1816
Hlavní autoři: Walton, Clare, King, Rachel, Rechtman, Lindsay, Kaye, Wendy, Leray, Emmanuelle, Marrie, Ruth Ann, Robertson, Neil, La Rocca, Nicholas, Uitdehaag, Bernard, van der Mei, Ingrid, Wallin, Mitchell, Helme, Anne, Angood Napier, Ceri, Rijke, Nick, Baneke, Peer
Médium: Journal Article
Jazyk:angličtina
Vydáno: England 01.12.2020
Témata:
Child
Female
Humans
Incidence
Male
Multiple Sclerosis - epidemiology
Prevalence
epidemiology
Multiple sclerosis
ISSN:1477-0970, 1477-0970
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:High-quality epidemiologic data worldwide are needed to improve our understanding of disease risk, support health policy to meet the diverse needs of people with multiple sclerosis (MS) and support advocacy efforts. The Atlas of MS is an open-source global compendium of data regarding the epidemiology of MS and the availability of resources for people with MS reported at country, regional and global levels. Country representatives reported epidemiologic data and their sources via survey between September 2019 and March 2020, covering prevalence and incidence in males, females and children, and age and MS type at diagnosis. Regional analyses and comparisons with 2013 data were conducted. A total of 2.8 million people are estimated to live with MS worldwide (35.9 per 100,000 population). MS prevalence has increased in every world region since 2013 but gaps in prevalence estimates persist. The pooled incidence rate across 75 reporting countries is 2.1 per 100,000 persons/year, and the mean age of diagnosis is 32 years. Females are twice as likely to live with MS as males. The global prevalence of MS has risen since 2013, but good surveillance data is not universal. Action is needed by multiple stakeholders to close knowledge gaps.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1477-0970
1477-0970
DOI:10.1177/1352458520970841